Varda Space Industries—a California start-up with deep roots in Cornell’s Space Systems Design Studio--launched its first test mission on a SpaceX rocket on June 12.
Varda’s goal is to create a fleet of satellites that will be used to carry out pharmaceutical research in the microgravity of Earth’s orbit. In the recent test, Varda’s 200-pound satellite successfully separated from the rocket.
Eventually, Varda will have a fleet of research and production capsules that will grow specific protein crystals while in space. These capsules will then de-orbit and parachute back to Earth, where the pharmaceutical materials inside will be used to make prescription drugs. Past studies have shown that growing some protein crystals in space leads to more perfect structures than shown by crystals grown on Earth. The more perfect structures have a positive effect on the pharmaceuticals these crystals are used to create.
Varda was founded by Cornell alumni Will Bruey ’11 M.Eng. ’12 in 2020 and has already raised more than $100 million in seed funding and grants from investors who are confident the technology will succeed. While at Cornell, Bruey was active in Professor Mason Peck’s Space Systems Design Studio, as was Varda’s director of autonomous systems Wendy Shimata ’09.
You can learn more about Varda and space manufacturing in this article from the MAE Newsletter.
Katherine Ruelan ’27, a five-year veteran of the U.S. Marine Corps, is majoring in mechanical engineering and attending Cornell full time thanks to a number of resources, including the Cornell... Read more about Veterans scholarship helps marine explore engineering passion
Cornell researchers have uncovered new details about how high-speed metallic collisions can form strong, durable atomic bonds, offering insights that could enhance 3D printing and other manufacturing... Read more about Supersonic microprojectiles reveal new insights into metal bonding
After decades of engineering probes to study natural environments, a Cornell engineer has adapted the technology to improve drug manufacturing processes with pharmaceutical company Merck. Read more about Snow probes adapted to improve pharmaceutical manufacturing
